Apple
hires secret team for treating diabetes: CNBC
Send a link to a friend
[April 13, 2017] (Reuters)
- Apple Inc has hired a team of biomedical
engineers as part of a secret initiative, initially envisioned by late
Apple co-founder Steve Jobs, to develop sensors to treat diabetes, CNBC
reported citing three people familiar with the matter.
|
An Apple spokeswoman declined to comment.
The engineers are expected to work at a nondescript office in Palo
Alto, California, close to the corporate headquarters, CNBC said.
(http://cnb.cx/2nGgn9P)
The news comes at the time when the line between pharmaceuticals and
technology is blurring as companies are joining forces to tackle
chronic diseases using high-tech devices that combine biology,
software and hardware, thereby jump-starting a novel field of
medicine called bioelectronics.
Last year, GlaxoSmithKline Plc and Google parent Alphabet Inc
unveiled a joint company aimed at marketing bioelectronic devices to
fight illness by attaching to individual nerves.
U.S. biotech firms Setpoint Medical and EnteroMedics Inc have
already shown early benefits of bioelectronics in treating
rheumatoid arthritis and suppressing appetite in the obese.
Other companies playing around the idea of bioelectronics include
Medtronic Plc , Proteus Digital Technology, Sanofi SA and Biogen Inc
.
[to top of second column] |
The company's shares were marginally up after the bell on Wednesday.
(Reporting by Divya Grover in Bengaluru; Editing by Sandra Maler and
Lisa Shumaker)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |